Agreement is centered around expanding medication access to patients
ScriptDrop Inc., a healthcare technology company focused on prescription access, and Roadie, a UPS company and crowdsourced delivery platform, began their partnership in fall 2020. During that time, ScriptDrop was searching for a partner who could provide same-day and urgent delivery.
Fast forward a couple of years, ScriptDrop has gone from manually posting delivery requests to Roadie's platform to a full active pharmaceutical ingredient (API) integration, which according to the involved parties, allows the both of them to mutually benefit from a streamlined workflow. In terms of patient access, Roadie's large local same-day delivery network and knowledge in last-mile logistics has allowed ScriptDrop to offer safe, secure, same-day delivery to patients no matter where they live.
The aforementioned healthcare tech company recently released its annual prescription access industry report, "Everything Old Is New Again: Social Determinants of Health and the Role of Prescription Delivery in Home Healthcare." This year, the report focuses in part on social determinants of health (SDOHs), which are non-medical factors that affect a person's health. One SDOH is "healthcare access and quality," which includes a person's vicinity to healthcare facilities and pharmacies.
"When it comes to accessing quality healthcare, your zip code shouldn't be a barrier to getting what you need,” says Marc Gorlin, Roadie CEO. “Fast, frictionless delivery isn't a nice-to-have for many industries; it's table stakes. And with ScriptDrop, it's a path to more equitable communities. We're proud to work with ScriptDrop to expand healthcare access nationwide."
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Study Connects COVID-19 Treatment Disparities to Gaps in Testing and Virtual Access
July 11th 2025New research finds that nearly half of the racial and ethnic disparities in outpatient COVID-19 antiviral prescriptions stem from encounter-level care barriers, such as limited access to rapid tests and telehealth, which emphasizes the need for systemic and practice-level reforms.